$82,511,281
Department of Health and Human Services·National Institutes of Health
to MAYO CLINIC
WORK BEGAN2019-09-15·LATEST ACTION2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_U19AG063911_075
Award description
ARTFL LEFFTDS LONGITUDINAL FRONTOTEMPORAL LOBAR DEGENERATION (ALLFTD)
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
The Buildout's read
What the model surfaced from this award
Confidence: high
In plain English
Latest obligation on a 2019 NIH cooperative agreement funding Mayo Clinic's longitudinal research into frontotemporal lobar degeneration.
Sub-sectors
nih-research-grantneurodegenerative-diseaselongitudinal-study
Why this matters
ALLFTD is a multi-year observational study tracking disease progression in FTD patients to identify biomarkers and inform future therapeutic development.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-31. Cost: $0.002739.
Period of performance
Start
2019-09-15
End
2025-09-14
Status
expired302 days ago
Sources
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_U19AG063911_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.